HIGHLIGHTS
- who: Julien Stievenart from the Ferrand University Hospital, Inserm, INRA USC2018, iSH, Clermont-Ferrand, France have published the paper: Case Report: TNFu03b1 Antagonists Are an Effective Therapy in Cardiac Sarcoidosis, in the Journal: (JOURNAL)
- what: The authors report a case series of CS successfully treated by tumor necrosis factor (TNF)u03b1 antagonists.
- how: The authors conducted a single-center retrospective study of the patients with CS treated by TNFu03b1 antagonists.
- future: To clarify TNFu03b1 antagonists` position in the treatment scheme of CS further studies are needed with control groups standardized treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.